Efficacy and safety of dupilumab in patients with severe chronic hand eczema with inadequate response or intolerance to alitretinoin: a randomized, double-blind, placebo-controlled phase IIb proof-of-concept study (vol 189, pg 400, 2023)

被引：0
|
作者：
Guardala, Noel A.
机构：
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 190卷 / 03期
关键词：
D O I：
10.1093/bjd/ljad482
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E24 / E26
页数：3
相关论文
共 50 条
  • [31] A Multicenter, Randomized, Double-Blind, Placebo-Controlled Switch Study to Evaluate the Safety, Tolerability, and Efficacy of Milnacipran in Patients with An Inadequate Response to Duloxetine for the Treatment of Fibromyalgia
    Bateman, Lucinda
    Spera, Allan
    Palmer, Robert H.
    Trugman, Joel M.
    Lin, Jennifer
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S628 - S628
  • [32] A double-blind, randomized, placebo-controlled study of the safety and efficacy of bicifadine in patients with chronic low back pain (CLBP)
    Apfel, S.
    Huang, N.
    Duncanson, E.
    Czobor, P.
    Wang, Q.
    Waldron, D.
    Odctalla, R.
    Stern, W.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S136 - S136
  • [33] SAFETY AND TOLERABILITY OF ARIMOCLOMOL IN PATIENTS WITH SPORADIC INCLUSION BODY MYOSITIS: A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE IIA PROOF-OF-CONCEPT TRIAL
    Machado, P.
    Miller, A.
    Herbelin, L.
    He, J.
    Noel, J.
    Wang, Y.
    McVey, A. L.
    Pasnoor, M.
    Gallagher, P.
    Statland, J.
    Brady, S.
    Lu, C. -H.
    Kalmar, B.
    Sethi, H.
    Samandouras, G.
    Holton, J.
    Greensmith, L.
    Barohn, R. J.
    Hanna, M. G.
    Dimachkie, M. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 164 - 164
  • [34] A multicenter, double-blind, randomized, placebo-controlled, phase IIb dose-finding study to evaluate efficacy and safety of spesolimab in patients with moderate-to-severe palmoplantar pustulosis
    Burden, A. David
    Bissonnette, Robert
    Navarini, Alexander A.
    Murakami, Masamoto
    Morita, Akimichi
    Mozzicato, Susan
    Ye, Binqi
    Baehner, Frank
    Terui, Tadashi
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB131 - AB131
  • [35] Efficacy and safety of topical delgocitinib in patients with chronic hand eczema: data from a randomized, double-blind, vehicle-controlled phase IIa study
    Worm, M.
    Bauer, A.
    Elsner, P.
    Mahler, V.
    Molin, S.
    Nielsen, T. S. S.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (05) : 1103 - 1110
  • [36] Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trial
    Yan, Kexiang
    Li, Fuqiu
    Bi, Xiaodong
    Han, Ling
    Zhang, Zhenghua
    Chen, Rixin
    Li, Yuye
    Zhang, Litao
    Wang, Xiaohua
    Li, Linfeng
    Lu, Jianyun
    Xu, Ai'e
    Yang, Sen
    Lu, Yan
    Sun, Jianfang
    Li, Zhiming
    Zhu, Xiaohong
    Jiang, Meiying
    Zhang, Siping
    Wang, Wenqing
    Li, Yanling
    Meng, Zudong
    Li, Hongyi
    Mou, Kuanhou
    Han, Xiuping
    Li, Shanshan
    Chen, Aijun
    Li, Xin
    Liu, Donghua
    Zhang, Chunlei
    Ji, Chao
    Wang, Yu
    Cheng, Hao
    Cui, Xiaojing
    Yao, Xiaoyan
    Bai, Xiaoyan
    Dong, Guangchao
    Xu, Jinhua
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2025, 92 (01) : 92 - 99
  • [37] Efficacy and Safety of Baricitinb in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Pediatric Patients with Moderate-to-Severe Atopic Dermatitis
    Torrelo, A.
    Rewerska, B.
    Paller, Amy
    Prakash, A.
    Zhu, D.
    Pontes, M.
    Wu, Wen-Shuo
    Eichenfield, Lawrence F.
    Boecker, Ulrike
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 99 - 99
  • [38] Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of prucalopride in pediatric patients with functional constipation ( vol 33 , 101144 , 2023)
    Cuffari, Carmen
    Spalding, William
    Achenbach, Heinrich
    Thakur, Manoj
    Gabriel, Andre
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2024, 39
  • [39] Efficacy and safety of zapnometinib in hospitalised adult patients with COVID-19 (RESPIRE): a randomised, double-blind, placebo-controlled, multicentre, proof-of-concept, phase 2 trial
    Rohde, Gernot
    Stenglein, Stephan
    Prozesky, Hans
    Manudhane, Ganesh
    Sandulescu, Oana
    Bauer, Martin
    Overend, Tim
    Koch, Winfried
    Neuschwander, Dennis
    Planz, Oliver
    Torres, Antoni
    Witzenrath, Martin
    ECLINICALMEDICINE, 2023, 65
  • [40] Rapid Onset of Response Observed with Certolizumab Pegol in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate: Efficacy and Safety Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study
    Bi, Liqi
    Li, Yuhui
    He, Lan
    Xu, Huji
    Gu, Jieruo
    Wang, Guochun
    Zhang, Zhiyi
    Liu, Yi
    Boehnlein, Marion
    Dunkel, Jochen
    Shao, Jing
    Harris, Kristina
    Li, Zhanguo
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
12345